RPG Life Sciences Limited (IN:RPGLIFE)
:RPGLIFE
Want to see IN:RPGLIFE full AI Analyst Report?
RPGLIFE Stock Chart & Stats
₹2303.55
-₹26.05(-1.12%)
At close: 4:00 PM EST
₹2303.55
-₹26.05(-1.12%)
Day’s Range― - ―
52-Week Range₹1,731.25 - ₹2,715.90
Previous CloseN/A
Volume11.08K
Average Volume (3M)3.23K
Market Cap
₹37.05B
Enterprise Value₹35.32B
Total Cash (Recent Filing)₹2.24B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)32.2
Beta0.79
Next Earnings
Jul 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.85%
Share Statistics
EPS (TTM)130.26
Shares Outstanding16,539,015
10 Day Avg. Volume8,652
30 Day Avg. Volume3,228
Financial Highlights & Ratios
PEG Ratio-0.72
Price to Book (P/B)5.08
Price to Sales (P/S)4.34
P/FCF Ratio-38.40K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage and a conservatively positioned balance sheet provide durable financial flexibility. Equity has compounded meaningfully, supporting asset growth and allowing the company to absorb cyclical shocks, fund targeted investments or M&A, and maintain operations without reliance on expensive external financing.
Stable Revenue GrowthConsistent mid-to-high single-digit top-line growth indicates resilient demand for its branded formulations and steady market penetration. This predictable revenue base supports medium-term planning, capacity utilization and recurring cash inflows that underpin sustainable operations and product portfolio reinvestment.
Branded Formulations & Domestic ReachA prescription-led branded portfolio sold through a field force and established channel network creates customer stickiness and repeat demand. Domestic market strength plus export presence diversifies revenue sources, helps pricing power in core therapies, and builds a durable commercial moat versus pure generics.
Bears Say
FY2026 Margin CompressionA sharp step-down in margins reduces intrinsic earnings power and the ability to self-fund growth. If driven by structural cost inflation, pricing pressure, or product-mix shifts, sustained margin weakness would lower return on equity and strain capital allocation, limiting long-term competitiveness and reinvestment.
Weakened Cash ConversionDeteriorating operating cash conversion and a move to slightly negative free cash flow constrain liquidity available for capex, working capital, dividends, or debt reduction. Over multiple quarters this reduces strategic flexibility and raises the importance of managing receivables, inventories, and capital spending tightly.
Earnings Volatility / EPS DeclineA large year-over-year EPS decline signals earnings volatility and possible structural pressure on profitability. This undermines predictability for reinvestment and shareholder returns, complicates forecasting, and may reflect margin, pricing or mix challenges that could persist absent operational improvements.
RPG Life Sciences Limited News
RPGLIFE FAQ
What was RPG Life Sciences Limited’s price range in the past 12 months?
RPG Life Sciences Limited lowest stock price was ₹1731.25 and its highest was ₹2715.90 in the past 12 months.
What is RPG Life Sciences Limited’s market cap?
RPG Life Sciences Limited’s market cap is ₹37.05B.
When is RPG Life Sciences Limited’s upcoming earnings report date?
RPG Life Sciences Limited’s upcoming earnings report date is Jul 24, 2026 which is in 56 days.
How were RPG Life Sciences Limited’s earnings last quarter?
RPG Life Sciences Limited released its earnings results on Apr 29, 2026. The company reported ₹18.08 earnings per share for the quarter, beating the consensus estimate of N/A by ₹18.08.
Is RPG Life Sciences Limited overvalued?
According to Wall Street analysts RPG Life Sciences Limited’s price is currently Overvalued.
Does RPG Life Sciences Limited pay dividends?
RPG Life Sciences Limited pays a Notavailable dividend of ₹20 which represents an annual dividend yield of 0.85%. See more information on RPG Life Sciences Limited dividends here
What is RPG Life Sciences Limited’s EPS estimate?
RPG Life Sciences Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RPG Life Sciences Limited have?
RPG Life Sciences Limited has 16,539,015 shares outstanding.
What happened to RPG Life Sciences Limited’s price movement after its last earnings report?
RPG Life Sciences Limited reported an EPS of ₹18.08 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.761%.
Which hedge fund is a major shareholder of RPG Life Sciences Limited?
Currently, no hedge funds are holding shares in IN:RPGLIFE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. It also provides generics primarily in area of immunosuppressant therapy; and finished dosage formulations for various therapies, such as nephrology, rheumatology, oncology, gastroenterology, cardiovascular, diabetology, orthopedics, neuropsychiatry, respiratory, nutritional, general, urology, anti-diabetic, anti-dengue, vitamins and minerals, gynecology and pediatrics, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
Technical Analysis
Bliss Gvs Pharma Limited
―
Hikal Limited
―
IOL Chemicals & Pharmaceuticals Ltd.
―
Solara Active Pharma Sciences Ltd.
―
Unichem Laboratories Limited
―